MIAMI--(BUSINESS WIRE)-- Summit Therapeutics Inc. (SMMT) (“Summit,” “we,” or the “Company”) today noted that Akeso, Inc. (Akeso, HKEX Code: 9926.HK) announced that ivonescimab was approved by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results